DeepCurrents Investment Group »

Bridgebio Pharma shares owned by DeepCurrents Investment Group

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by DeepCurrents Investment Group from 13F filings

Historical chart of DeepCurrents Investment Group investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by DeepCurrents Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by DeepCurrents Investment Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $17M 9.5M 1.80

More positions owned by DeepCurrents Investment Group

Interdigital Note 3.500% 6/0 (Principal)
Netflix Call Option (NFLX)
Strategy Cl A New Put Option (MSTR)
Repligen Corp Note 1.000%12/1 (Principal)
Cloudflare Note 8/1 (Principal)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
Draftkings Note 3/1 (Principal)
Workiva Note 1.250% 8/1 (Principal)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Coinbase Global Note 0.500% 6/0 (Principal)
Strategy Note 0.625% 9/1 (Principal)
Teladoc Health Note 1.250% 6/0 (Principal)
Upwork Note 0.250% 8/1 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Snowflake Note 10/0 (Principal)

View all positions for DeepCurrents Investment Group

Top funds holding Bridgebio Pharma

Wolverine Asset Management
Linden Advisors
Steelhead Partners
Capstone Investment Advisors
Lazard Asset Management
Millennium Management
FMR
Graham Capital Management
683 Capital Management
Aristeia Capital
Tenor Capital Management
M&G
State Street Corporation
DeepCurrents Investment Group
BlackRock

View all funds holding Bridgebio Pharma